Discovery of natural‐derived M pro inhibitors as therapeutic candidates for COVID‐19: Structure‐based pharmacophore screening combined with QSAR analysis
Molecular Informatics · 2023-04 · 42 (4)
DOI: 10.1002/minf.202200198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Informatics, online erschienen am 10.02.2023. Verfasst von Mohammad A Khanfar und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Alfaisal University, Al Takhassusi Rd, P. O. Box 50927, Riyadh, 11533, Saudi Arabia. Hauptthemen laut MEDLINE: COVID-19, Biological Products. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: College of Pharmacy and Office of Research and Innovation (ORI) at Alfaisal University.
Abstract (Originalsprache)
The main protease (M pro ) is an essential enzyme for the life cycle of SARS‐CoV‐2 and a validated target for treatment of COVID‐19 infection. Structure‐based pharmacophore modeling combined with QSAR calculations were employed to identify new chemical scaffolds of M pro inhibitors from natural products repository. Hundreds of pharmacophore models were manually built from their corresponding X‐ray crystallographic structures. A pharmacophore model that was validated by receiver operating characteristic (ROC) curve analysis and selected using the statistically optimum QSAR equation was implemented as a 3D‐search tool to mine AnalytiCon Discovery database of natural products. Captured hits that showed the highest predicted inhibitory activities were bioassayed. Three active M pro inhibitors (pseurotin A, lactupicrin, and alpinetin) were successfully identified with IC 50 values in low micromolar range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Alfaisal University, Al Takhassusi Rd, P. O. Box 50927, Riyadh, 11533, Saudi Arabia.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, P.O Box 13140, Amman, 11942, Jordan.
Förderung
- College of Pharmacy and Office of Research and Innovation (ORI) at Alfaisal University
Zitieren
APA
Khanfar, M. A., Salaas, N., & Abumostafa, R. (2023). Discovery of natural‐derived M pro inhibitors as therapeutic candidates for COVID‐19: Structure‐based pharmacophore screening combined with QSAR analysis. Molecular Informatics, 42(4). https://doi.org/10.1002/minf.202200198
Vancouver
Khanfar MA, Salaas N, Abumostafa R. Discovery of natural‐derived M pro inhibitors as therapeutic candidates for COVID‐19: Structure‐based pharmacophore screening combined with QSAR analysis. Molecular Informatics. 2023;42(4). doi:10.1002/minf.202200198
BibTeX
@article{Khanfar2023,
author = {Khanfar, Mohammad A and Salaas, Nada and Abumostafa, Reem},
title = {Discovery of natural‐derived M pro inhibitors as therapeutic candidates for COVID‐19: Structure‐based pharmacophore screening combined with QSAR analysis},
journal = {Molecular Informatics},
year = {2023},
volume = {42},
number = {4},
doi = {10.1002/minf.202200198}
}
EUVIMED